United Therapeutics holds the cleaner structural position, with valuation as the main driver and stability adding further support. MSCI still has the edge on profitability, which keeps the comparison from looking entirely one-sided. On the market side, United Therapeutics is in better shape — its trend is intact while MSCI's trend has broken down. That puts structure and market broadly in agreement — United Therapeutics's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels.
This is not just a one-metric split: both valuation and stability materially support the lead. The overall score gap is 8 points in favour of United Therapeutics Corporation.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
Most of the shared profile comes through margin consistency and revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Structure stays fairly close here, while current pricing still looks more supportive for United Therapeutics Corporation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The multiple-based pricing edge comes from a forward P/E that is 7.8 turns lower.
Profitability still favours MSCI, with a 11-point operating margin advantage keeping the comparison from looking fully resolved.
Valuation is the clearest driver of the lead, with stability adding further support — though profitability still provides a real counterweight.
Break down the MSCI vs UTHR comparison across all dimensions with the full interactive tool.
Explore how MSCI and UTHR each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.